期刊文献+

推进“三高”共管,全面防控心血管病 被引量:4

下载PDF
导出
摘要 心血管疾病(cardiovascular disease,CVD)已成为我国居民最主要的危害健康的疾病,也是导致预期寿命受损、因病致贫、因病返贫的主要疾病。近年来,CVD的发病率和患病率持续上升,推算现患人数3.30亿,其中脑卒中1300万,冠心病1100万;死亡人数仍在上升.
作者 王增武
出处 《心脑血管病防治》 2023年第2期1-2,11,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
  • 相关文献

参考文献6

二级参考文献82

  • 1胡大一,孙艺红.正确认识阿司匹林“抵抗”[J].中华心血管病杂志,2006,34(12):1057-1058. 被引量:10
  • 2Yang WY , Lu JM, Weng JP, et al. Prevalence of Diabetes a- mong Menand Women in China. N Engl J Med, 2010,362 : 1090- 1011.
  • 3Thattacharyya OK, Shah BR, Booth GL. Management of cardio- vascular disease in patients with diabetes:the 2008 Canadian Di- abetes Association guidelines. CMAJ, 2008,179 : 920-926.
  • 4Executive Summary of The Third Report of The National Cho lesterol Education Program (NCEP)Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In A- dults (Adult Treatment Panel III). JAMA, 2001, 285: 2486-2497.
  • 5American Diabetes Association. Executive summary: Standards of medical care in diabetes-2014. Diabetes Care, 2014,37 Suppl1 : $14-$80.
  • 6Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012) :The i{th joint task force of the european society of car- diology and other societies on cardiovascular disease preven'don in clinical practice (constituted by representatives o{ nine socie- ties and by invited experts). G Ital Cardiol (Rome), 2013,14: 328-392.
  • 7Diabetes Australia Guideline Development Consortium, National Medical Research Council[EB/OL]. National Evidence Based Guidelines for the Management of Type 2 Diabetes Mellitus,in Part 5, Prevention and Detection of Macrovaseular Disease in Type 2 Diabetes 2004, Australian Centre for Diabetes Strate- gies: Sydney, Australia. (2014-11-11)http://www. nhmrc, gov. cn/guidelines-publieations/di7 diS-di10-dill-di12-di13, html.
  • 8Nationwide Assessment of Cardiovascular Risk Factors: Blood Pressure, Blood Lipid, and Blood Glucose, in Chinese Patients with Type 2 Diabetes CCMR - 3B STUDY[EB/OL]www. elinicaltrials, gov, NCT01128205, Supported in part by a re- search grant from Merck Sharp Dohme (China) Ltd. (2014-11 11) http://www, hhmrc, gov. cn/guidelines-publieations/di7- diS-dil0 dill-dil2-dil3, html.
  • 9Ji L, Hu D,Pan C, et al. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes pa- tients. Am J Med,2013,126:e11-e22.
  • 10World Health Organization. Definition, diagnosis and classifica- tion of diabetes mellitus and its complications. Geneva,Switzer- land: World Health Organization, 1999 : 31-33.

共引文献887

同被引文献64

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部